These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Apolipoprotein E immunoreactivities in normal human ovary and ovarian neoplasms]. Umemori Y; Chiba H; Tokusashi Y; Miyokawa N Rinsho Byori; 1998 Jan; 46(1):69-72. PubMed ID: 9492541 [TBL] [Abstract][Full Text] [Related]
9. [Molecular markers of ovarian carcinoma]. Dobryszycka W Postepy Hig Med Dosw; 2000; 54(4):495-518. PubMed ID: 11016269 [TBL] [Abstract][Full Text] [Related]
10. The importance of test positive predictive value in ovarian cancer screening. Greene MH; Feng Z; Gail MH Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386 [No Abstract] [Full Text] [Related]
11. A review and an update on the screening of epithelial ovarian cancer. Reynolds EA; Moller KA Curr Probl Cancer; 2006; 30(5):203-32. PubMed ID: 16996383 [No Abstract] [Full Text] [Related]
12. [Importance of tumor markers for the diagnosis of ovarian carcinoma]. Serdev V; Mateeva E; Ankov V; Mikhaĭlova-Todorova S; Ivanova I Akush Ginekol (Sofiia); 1987; 26(4):60-4. PubMed ID: 3674327 [No Abstract] [Full Text] [Related]
14. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening. Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795 [TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer]. Tang BJ; Li L; Xu J Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406 [TBL] [Abstract][Full Text] [Related]
16. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management? Narod S Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541 [No Abstract] [Full Text] [Related]
18. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles. De Smet F; Pochet NL; De Moor BL; Van Gorp T; Timmerman D; Vergote IB; Hartmann LC; Damokosh AI; Hoersch S Clin Cancer Res; 2005 Nov; 11(21):7958-9; author reply 7959. PubMed ID: 16278422 [No Abstract] [Full Text] [Related]
19. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria. Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511 [No Abstract] [Full Text] [Related]
20. [Problems for tumor markers in gynecological malignancies]. Li GT Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):2-4. PubMed ID: 18366922 [No Abstract] [Full Text] [Related] [Next] [New Search]